Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone versus ramipril combination therapy versus ramipril monotherapy in non-diabetic hypertensive patients with low-grade inflammation
2006-004028-35Phase 2Completed
- Sponsor
- Takeda
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pioglitazone and ramipril in atherosclerosis and hypertension (HTN) (3 arms), sponsored by Takeda. Primary endpoint: Change in high-sensitivity C-reactive protein. Started Nov 2006; status: completed.
02
Drugs
pioglitazoneramipril
03
Conditions
atherosclerosishypertension (HTN)
Beyond the preview
Go deeper on 2006-004028-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004028-35.